FI963566A0 - Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessa - Google Patents
Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessaInfo
- Publication number
- FI963566A0 FI963566A0 FI963566A FI963566A FI963566A0 FI 963566 A0 FI963566 A0 FI 963566A0 FI 963566 A FI963566 A FI 963566A FI 963566 A FI963566 A FI 963566A FI 963566 A0 FI963566 A0 FI 963566A0
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- methods
- compositions containing
- piperazine derivatives
- new piperazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR19950000399 | 1995-01-11 | ||
KR1019950043607A KR0162710B1 (ko) | 1995-01-10 | 1995-11-24 | 신규 피페라진 유도체 및 그 제조방법 |
PCT/KR1996/000005 WO1996021648A1 (en) | 1995-01-11 | 1996-01-10 | New piperazine derivatives and methods for the preparation thereof and compositions containing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
FI963566A0 true FI963566A0 (sv) | 1996-09-10 |
FI963566A FI963566A (sv) | 1996-09-10 |
Family
ID=26630862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI963566A FI963566A (sv) | 1995-01-11 | 1996-09-10 | Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessa |
Country Status (16)
Country | Link |
---|---|
US (1) | US5780472A (sv) |
EP (1) | EP0749425A1 (sv) |
JP (1) | JP2978967B2 (sv) |
CN (1) | CN1128139C (sv) |
AU (1) | AU699619B2 (sv) |
BR (1) | BR9605309A (sv) |
CA (1) | CA2184919C (sv) |
CZ (1) | CZ288002B6 (sv) |
FI (1) | FI963566A (sv) |
HU (1) | HUP9602489A3 (sv) |
NO (1) | NO307459B1 (sv) |
NZ (1) | NZ298499A (sv) |
PL (1) | PL183865B1 (sv) |
RO (1) | RO115159B1 (sv) |
SK (1) | SK282252B6 (sv) |
WO (1) | WO1996021648A1 (sv) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0755923B1 (en) * | 1995-01-23 | 2005-05-04 | Daiichi Suntory Pharma Co., Ltd. | Ameliorant or remedy for symptoms caused by Ischemic diseases and Phenylpiperidine compounds useful therefor |
ATE241600T1 (de) * | 1996-06-29 | 2003-06-15 | Samjin Pharm Co Ltd | Piperazin-derivate und verfahren zu ihrer herstellung |
US6174905B1 (en) | 1996-09-30 | 2001-01-16 | Mitsui Chemicals, Inc. | Cell differentiation inducer |
US6794392B1 (en) | 1996-09-30 | 2004-09-21 | Schering Aktiengesellschaft | Cell differentiation inducer |
KR100420616B1 (ko) * | 1996-12-26 | 2004-05-17 | 동화약품공업주식회사 | 신규테레프탈산아미드유도체 |
CA2345146C (en) | 1998-09-22 | 2010-02-23 | Yamanouchi Pharmaceutical Co., Ltd. | Cyanophenyl derivative |
CA2330942C (en) * | 1999-03-03 | 2004-11-23 | Samjin Pharmaceutical Co., Ltd. | Piperazine derivatives and process for the preparation thereof |
NZ523526A (en) | 2000-07-20 | 2004-10-29 | Neurogen Corp | Diaryl piperazines as capsaicin receptor ligands |
DE10035908A1 (de) * | 2000-07-21 | 2002-03-07 | Asta Medica Ag | Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel |
US6432957B1 (en) * | 2001-06-29 | 2002-08-13 | Kowa Co., Ltd. | Piperazine derivative |
AU2002344951A1 (en) * | 2001-07-02 | 2003-01-21 | Boehringer Ingelheim International Gmbh | Substituted piperazine and diazepanes as histamine h3 receptor agonists |
EA006243B1 (ru) * | 2001-10-22 | 2005-10-27 | Пфайзер Продактс Инк. | Производные пиперазина с антагонистической активностью к рецептору ccr1 |
IL162270A0 (en) * | 2001-12-14 | 2005-11-20 | Novo Nordisk As | Compounds and uses thereof for decreasing activityof hormone-sensitive lipase |
PT1472225E (pt) | 2002-02-01 | 2010-07-30 | Euro Celtique Sa | 2-piperazina-piridinas uteis para tratar a dor |
WO2004002983A2 (en) | 2002-06-28 | 2004-01-08 | Euro-Celtique, S.A. | Therapeutic piperazine derivatives useful for treating pain |
US7262194B2 (en) | 2002-07-26 | 2007-08-28 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
US7157462B2 (en) | 2002-09-24 | 2007-01-02 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
WO2004083235A2 (en) * | 2003-03-19 | 2004-09-30 | Exelixis Inc. | Tie-2 modulators and methods of use |
RS56194B1 (sr) * | 2004-12-30 | 2017-11-30 | Janssen Pharmaceutica Nv | Derivativi fenilamida 4-(benzil)-piperazin-1-karboksilne kiseline i slična jedinjenja kao modulatori hidrolaze amida masnih kiselina (faah) za lečenje anksioznosti, bola i ostalih stanja |
ES2433290T3 (es) * | 2005-02-17 | 2013-12-10 | Astellas Pharma Inc. | Derivados de piperazina para el tratamiento de la incontinencia urinaria y el dolor |
WO2007005510A1 (en) | 2005-06-30 | 2007-01-11 | Janssen Pharmaceutica N.V. | N-heteroarylpiperazinyl ureas as modulators of fatty acid amide hydrolase |
JPWO2007020888A1 (ja) | 2005-08-12 | 2009-02-26 | 武田薬品工業株式会社 | 脳・神経細胞保護剤および睡眠障害治療薬 |
AP2780A (en) | 2006-10-18 | 2013-09-30 | Pfizer Prod Inc | Biaryl ether urea compounds |
JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine / piperazine derivatives |
US8633197B2 (en) | 2007-06-08 | 2014-01-21 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
CA2687754C (en) | 2007-06-08 | 2015-12-08 | Janssen Pharmaceutica N.V. | Piperidine, piperazine derivatives for use as dgat inhibitors |
CA2687912C (en) | 2007-06-08 | 2015-11-03 | Janssen Pharmaceutica N.V. | Piperidine/piperazine derivatives |
CA2702171A1 (en) * | 2007-10-10 | 2009-04-16 | Takeda Pharmaceutical Company Limited | Amide compound |
UY31863A (es) | 2008-06-05 | 2010-01-05 | Janssen Pharmaceutica Nv | Combinaciones de drogas que comprenden un inhibidor de dgat y un agonista de ppar |
WO2011060026A1 (en) | 2009-11-12 | 2011-05-19 | Jansen Pharmaceutica Nv | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
EP3373935B1 (en) * | 2015-11-12 | 2021-09-01 | Merck Sharp & Dohme Corp. | Cyanopyridine derivatives as liver x receptor beta agonists, compositions, and their use |
JP2019533022A (ja) * | 2016-10-24 | 2019-11-14 | ユマニティ セラピューティクス,インコーポレーテッド | 化合物及びその使用 |
US11873298B2 (en) | 2017-10-24 | 2024-01-16 | Janssen Pharmaceutica Nv | Compounds and uses thereof |
JPWO2022118966A1 (sv) * | 2020-12-04 | 2022-06-09 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
OA04700A (fr) * | 1973-05-15 | 1980-07-31 | Rhone Poulenc Sa | Nouveaux dérivés de la naphtyridine et leur procédé de préparation. |
AU7580187A (en) * | 1986-06-23 | 1988-01-12 | Upjohn Company, The | Androstane-type and cortical aminoesters |
US4960776A (en) * | 1987-01-28 | 1990-10-02 | A. H. Robins Company, Inc. | 4-aryl-N-(alkylaminoalkyl, heterocyclicamino and heterocyclicamino)alkyl)-1-piperazinecarboxamides |
JPH02142770A (ja) * | 1988-11-25 | 1990-05-31 | Shigeki Shin | ピペラジン系誘導体 |
JPH03141258A (ja) * | 1989-10-25 | 1991-06-17 | Kowa Co | 新規なピペラジン誘導体 |
DE4216364A1 (de) * | 1991-12-14 | 1993-11-25 | Thomae Gmbh Dr K | Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
US5196428A (en) * | 1992-04-03 | 1993-03-23 | Bristol-Myers Squibb Company | Imidazo[4,5-b]qinolinyl oxy alkyl ureas |
-
1996
- 1996-01-10 EP EP96900459A patent/EP0749425A1/en not_active Withdrawn
- 1996-01-10 SK SK889-96A patent/SK282252B6/sk unknown
- 1996-01-10 CA CA002184919A patent/CA2184919C/en not_active Expired - Lifetime
- 1996-01-10 AU AU44007/96A patent/AU699619B2/en not_active Expired
- 1996-01-10 PL PL96316613A patent/PL183865B1/pl unknown
- 1996-01-10 NZ NZ298499A patent/NZ298499A/en not_active IP Right Cessation
- 1996-01-10 HU HU9602489A patent/HUP9602489A3/hu unknown
- 1996-01-10 CZ CZ19962960A patent/CZ288002B6/cs not_active IP Right Cessation
- 1996-01-10 CN CN96190006A patent/CN1128139C/zh not_active Expired - Lifetime
- 1996-01-10 BR BR9605309A patent/BR9605309A/pt unknown
- 1996-01-10 US US08/676,174 patent/US5780472A/en not_active Expired - Lifetime
- 1996-01-10 JP JP8521570A patent/JP2978967B2/ja not_active Expired - Lifetime
- 1996-01-10 WO PCT/KR1996/000005 patent/WO1996021648A1/en not_active Application Discontinuation
- 1996-01-10 RO RO96-01781A patent/RO115159B1/ro unknown
- 1996-09-10 FI FI963566A patent/FI963566A/sv unknown
- 1996-09-10 NO NO963792A patent/NO307459B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
JPH09511764A (ja) | 1997-11-25 |
NO307459B1 (no) | 2000-04-10 |
HUP9602489A3 (en) | 1998-01-28 |
CZ288002B6 (cs) | 2001-03-14 |
PL316613A1 (en) | 1997-01-20 |
EP0749425A1 (en) | 1996-12-27 |
NO963792D0 (no) | 1996-09-10 |
NO963792L (no) | 1996-11-11 |
WO1996021648A1 (en) | 1996-07-18 |
SK88996A3 (en) | 1997-05-07 |
CZ296096A3 (en) | 1997-02-12 |
CN1128139C (zh) | 2003-11-19 |
SK282252B6 (sk) | 2001-12-03 |
FI963566A (sv) | 1996-09-10 |
HUP9602489A2 (en) | 1997-08-28 |
PL183865B1 (pl) | 2002-07-31 |
HU9602489D0 (en) | 1996-11-28 |
US5780472A (en) | 1998-07-14 |
NZ298499A (en) | 1998-01-26 |
AU699619B2 (en) | 1998-12-10 |
AU4400796A (en) | 1996-07-31 |
CA2184919C (en) | 2000-03-14 |
CA2184919A1 (en) | 1996-07-18 |
JP2978967B2 (ja) | 1999-11-15 |
CN1145620A (zh) | 1997-03-19 |
RO115159B1 (ro) | 1999-11-30 |
BR9605309A (pt) | 1997-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI963566A0 (sv) | Nya piperazinderivat och föfaranden för framställning av dem och kompositioner innehållande dessa | |
EE9500064A (et) | Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid | |
EE200000168A (et) | Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid | |
FI942913A0 (sv) | Isatinderivat, förfarande för deras framställning och farmaceutiska kompositioner innehållande dem | |
NO973479L (no) | Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme | |
FI964395A (sv) | Nya erytromycinderivater, förfarande för framställning av dessa och deras användning som läkemedel | |
EE04498B1 (et) | Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon | |
EE200000707A (et) | Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
EE03231B1 (et) | Tetratsüklilised derivaadid, nende valmistamismeetod ja kasutamine | |
HUP9901037A3 (en) | Piperazine derivatives,preparation and use thereof, pharmaceutical compositions containing these compounds | |
FI960889A (sv) | Naftylföreningar, mellanprodukter, kompositioner och förfaranden | |
EE9700333A (et) | Substitueeritud 4-fenüülaminotiasoolid, nende valmistamise meetod ja neid sisaldavad farmakoloogilised kompositsioonid | |
FI972309A (sv) | 2-heterocyklyloxi- och tiometyl-1,2,5-tiadiazolidin-3-on-1,1-dioxider, kompositioner innehållande dessa och förfarande för deras framställning | |
EE9800302A (et) | Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat | |
EE9900015A (et) | Sünteetilised polüsahhariidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid | |
EE9800426A (et) | Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
EE03825B1 (et) | 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
FI950625A (sv) | Polysubstituerade 3-acylamino-5-fenyl-1,4-bensodiazepin-2-on derivat, förfarande för framställning av dessa och farmaceutiska kompositioner innehållande dessa | |
EE9800145A (et) | Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena | |
HUP9902668A3 (en) | Piperazine derivatives, pharmaceutical compositions containing them and their use | |
FI972306A0 (sv) | Substituerade 2-arylkarbonyloximetyl-1,2,5-tiadiazolidin-3-oni-1,1-diozid-derivat och dessa innehållande kompositioner och förfaranden för deras användning | |
FI960316A0 (sv) | Oxatiolaner, förfarande för deras framställning och farmaceutiska kompositioner innehållande desamma | |
FI956278A0 (sv) | Substituerade 4-fenyltiazolderivat, förfarande för deras framställnin g och farmaceutiska kompositioner innehållande dem | |
HU9700955D0 (en) | Substituted 2-naphtoylguanidine derivatives, their production, their use and pharmaceutical compositions containing them | |
EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine |